Skip to content

Author

Charles P. Hannon

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Preoperative Weight Loss Before Total Joint Arthroplasty Using Novel Glucagon-Like Peptide-1 Agonists

Background This study determined the prevalence of glucagon-like peptide-1 (GLP-1) use before total joint arthroplasty (TJA), measured weight loss of patients on GLP-1s, and evaluated if GLP-1s were associated with outcomes. Methods We identified 6482 patients (2990 hips; 3492 knees) who had primary TJAs between 2019 a...

Michael W. Seward, Emmett J. Cleary, Anthony C. DeNovio et al. · 0 citations
Sep 2026

Cost Consequences of Enabling Technologies in Primary Total Hip Arthroplasty: A Propensity Matched Cohort Study.

Technology-assisted THA was associated with modest increases in index and 90-day episode-of-care costs compared with manual techniques, and further evaluation of cost-effectiveness and broader clinical benefits is warranted as the use of enabling technologies expands.

Jaques L. Williams, Adrián E. González-Bravo, James P. Moriarty et al. · 0 citations
Sep 2026

Revision Indication Is Associated with Early Mortality After Revision Total Hip Arthroplasty: A Population-Based Study.

Revision THA carries a low 30- and 90-day mortality risk that is not associated with the extent of revision, but is strongly impacted by the indication for revision, which faces a 3- and 4-fold higher risk of mortality within 90 days compared to aseptic loosening.

D. J. Restrepo, Adrián E. González-Bravo, S. G. Guarin Perez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.